Crossmark

Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force

Crossref DOI link: https://doi.org/10.14283/jpad.2021.36

Published Print: 2021-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kaye, Jeffrey

Aisen, P.

Amariglio, R.

Au, R.

Ballard, C.

Carrillo, M.

Fillit, H.

Iwatsubo, T.

Jimenez-Maggiora, G.

Lovestone, S.

Natanegara, F.

Papp, K.

Soto, M.E.

Weiner, M.

Vellas, B.
License Information

Text and Data Mining valid from 2021-10-01

Text and Data Mining valid from 2021-10-01

Version of Record valid from 2021-06-28
More Information

This article is maintained by: Elsevier

Article Title: Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2021.36

Content Type: article

Copyright: Copyright © 2021 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS